PROGNOSTIC IMPACT OF PROMOTER-HYPERMETHYLATED SFRP1 IN PANCREATIC DUCTAL ADENOCARCINOMA: A BLOOD-BASED BIOMARKER STUDY

Benjamin Stubbe

Publikation: Ph.d.-afhandling

68 Downloads (Pure)

3 Tidsskriftartikel

3 resultater

2023
Promoter hypermethylation of SFRP1 as a prognostic and potentially predictive blood-based biomarker in patients with localized pancreatic ductal adenocarcinoma
Stubbe, B. E., Larsen, A. C., Madsen, P. H., Krarup, H. B., Pedersen, I. S., Lundbye-Christensen, S., Hansen, C. P., Hasselby, J. P., Johansen, A. Z., Thorlacius-Ussing, O., Johansen, J. S. & Henriksen, S. D., 2 jun. 2023, I: Frontiers in Oncology. 13, 11 s., 1211292.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Åben adgang
Fil
26 Downloads (Pure)
Promoter hypermethylation of SFRP1 as a prognostic and potentially predictive blood-based biomarker in patients with stage III or IV pancreatic ductal adenocarcinoma
Stubbe, B., Madsen, P. H., Larsen, A. C., Krarup, H. B., Pedersen, I. S., Johansen, J. S., Henriksen, S. D. & Thorlacius-Ussing, O., aug. 2023, I: Pancreatology. 23, 5, s. 512-521 10 s.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Åben adgang
Fil
44 Downloads (Pure)
2021
Validation of SFRP1 Promoter Hypermethylation in Plasma as a Prognostic Marker for Survival and Gemcitabine Effectiveness in Patients with Stage IV Pancreatic Adenocarcinoma
Stubbe, B. E., Henriksen, S. D., Madsen, P. H., Larsen, A. C., Krarup, H. B., Pedersen, I. S., Johansen, M. N. & Thorlacius-Ussing, O., 15 nov. 2021, I: Cancers. 13, 22, 15 s., 5717.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Åben adgang
Fil
7 Citationer (Scopus)

35 Downloads (Pure)